Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies

SIMPLE SUMMARY: There is currently no effective therapy available for triple-negative breast cancer. To look for potentially effective treatment, we used the 4T1 mouse model of triple-negative breast carcinoma to study the therapeutic response of TheraVac (an antitumor therapeutic vaccination regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahar, Saifun, Huang, Yue, Nagy, Bethany A., Zebala, John A., Maeda, Dean Y., Rudloff, Udo, Oppenheim, Joost J., Yang, De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136945/
https://www.ncbi.nlm.nih.gov/pubmed/37190294
http://dx.doi.org/10.3390/cancers15082366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136945/
https://www.ncbi.nlm.nih.gov/pubmed/37190294
http://dx.doi.org/10.3390/cancers15082366

Ejemplares similares